Listed

Cumberland Pharmaceuticals Inc: Form 10-Q for the period ended Mar 31, 2014

Filed with the SEC on May 12, 2014 and accepted by EDGAR at May 12, 2014, 17:07 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-01-01 to 2014-03-31$8.1mus-gaap:SalesRevenueNet
Cost of revenue3 months2014-01-01 to 2014-03-31$1.1mus-gaap:CostOfGoodsSold
Research and development3 months2014-01-01 to 2014-03-31$826.4kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-01-01 to 2014-03-31$408.1kus-gaap:OperatingIncomeLoss
Interest expense3 months2014-01-01 to 2014-03-31$12.2kus-gaap:InterestExpense
Income tax3 months2014-01-01 to 2014-03-31$188.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-01-01 to 2014-03-31$286.3kus-gaap:NetIncomeLoss
Diluted EPS3 months2014-01-01 to 2014-03-31$0.02us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-01-01 to 2014-03-31$0.02us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-01-01 to 2014-03-3118,161,680 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2014-01-01 to 2014-03-31$982.6kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2014-01-01 to 2014-03-31$29.8kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases3 months2014-01-01 to 2014-03-31$919.6kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-03-31$39.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-03-31$69.3mus-gaap:AssetsCurrent
Total assetsAt period end2014-03-31$91.1mus-gaap:Assets
Current liabilitiesAt period end2014-03-31$11.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-03-31$12.1mus-gaap:Liabilities
Shareholders' equityAt period end2014-03-31$79.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001087294-14-000021. Last ingested by Listed: Nov 14, 2026, 23:39 ET. Listed shows no prices and gives no investment advice.